Clinical Trial Update: Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is recruiting to assess changes in multi-parametric MRI in people with Multiple Sclerosis treated with Clemastine Fumarate a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Clemastine Fumarate (clemastine fumarate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting | Phase 1, Phase 2 | Status: RECRUITING